Amoxicillin And Clavulanate Potassium Powder, For Suspension
Product Images NDC 16714-294

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 16714-294). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (600 mg/42.9 mg per 5 mL (75 mL Bottle))

This is a description of a medication called Amoxicillin and Clavulanate Potassium for Oral Suspension, USP. It is reconstituted with 71 mL of water and provides 600 mg of amoxicillin, USP trihydrate, and 42.9 mg of clavulanic acid, clavulanate potassium per 5 mL. The medication must be kept refrigerated and discarded after ten days. It contains phenylalanine and should be kept out of reach of children. The net contents are equivalent to 9 g of amoxicillin and 0.644 g of clavulanic acid. The manufacturing company is Aurobindo Pharma Limited in Hyderabad, India, and the medication is distributed by Northstar Rx LLC in Memphis, TN.*

FDA Label Image

Amoxicillin Chemical Structure (Amoxiclav Str1)

FDA Label Image

Clavulanate Potassium Chemical Structure (Amoxiclav Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.